Across the recent three months, 7 analysts have shared their insights on CG Oncology (NASDAQ:CGON), expressing a variety of opinions spanning from bullish to bearish. The table below summarizes their ...
In the latest quarter, 10 analysts provided ratings for CG Oncology (NASDAQ:CGON), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results